Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-immunogenicity and safety of corifollitropin alfa (Org 36286) in repeated COS cycles
2004-004966-34Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of corifollitropin alfa in superovulation, sponsored by Organon & Co. Primary endpoints: Non-immunogenicity of Org 36286 and Safety of Org 36286. Started Jun 2005; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
superovulation
Beyond the preview
Go deeper on 2004-004966-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004966-34.